Your session is about to expire
← Back to Search
Zio®XT Monitor Arm for Atrial Fibrillation (GUARD-AF Trial)
GUARD-AF Trial Summary
This trial will test if a detection intervention for atrial fibrillation or atrial flutter can reduce the incidence of stroke in people over 70.
- Atrial Fibrillation
- Atrial Flutter
GUARD-AF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.GUARD-AF Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there still vacancies for people to join this clinical experiment?
"According to clinicaltrials.gov, the initial posting for this medical trial was on December 17th 2019 and its last update occurred on November 17th 2022; as a result, it is not presently seeking candidates. However, 482 other studies are currently welcoming participants."
How many locations are currently conducting this research endeavor?
"This investigation is recruiting up to 100 patients from Local Institution - 0132 in Palm Harbor, Local Institution - 0005 in Detroit, and Local Institution - 0345 in Evergreen Park along with several other clinics."
What potential adverse effects could patients face from this treatment?
"Powered's experts rated the safety of this intervention a 3, due to its approval status as part of Phase 4 clinical trials."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger